<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02669498</url>
  </required_header>
  <id_info>
    <org_study_id>057/12</org_study_id>
    <nct_id>NCT02669498</nct_id>
  </id_info>
  <brief_title>Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal</brief_title>
  <official_title>Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kantonsspital Baden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two recently published articles need to be cited to explain the rationale for our study since
      both studies conclude with contrary findings: The first one is &quot;The post-reproductive
      Fallopian tube: better removed?&quot; and the other is termed &quot;Factors associated with age of
      onset and type of menopause in a cohort of UK women&quot;.

      In essence, while Dietl et al suggest to remove the Fallopian tube routinely in every
      hysterectomy and every sterilization procedure after 35 yrs of age, Pokoradi et al showed
      that pelvic surgical procedures and even simple tubal sterilization are associated with an
      earlier menopause. Hence, this is an important issue as early menopause leads to adverse
      health status.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two study findings lead to conflictive points of view. On the one hand a routine removal of
      the Fallopian tubes is proclaimed to reduce cancer risk, on the other hand we know that
      surgical pelvic procedures result in early onset of menopause. Pokoradi et al were not able
      to distinctively tell which part of pelvic surgery (ie hysterectomy, oophorectomy,
      salpingectomy, tubal ligation?) is affecting menopause because data was not providing
      surgical details. Nevertheless, Dietl et al's statement &quot;Timing of menopause and other
      long-term effects have not been studied yet...thus all negative effects are still
      speculative&quot;1 can only partly be agreed upon regarding Pokoradi's findings. It might be too
      early to proclaim a routine Fallopian tube removal as long as there is no data on how much
      this procedure affects ovarian function. This is further supported by another statement in
      their study &quot;Although most malignant serous &quot;ovarian&quot; carcinomas originate from the distal
      Fallopian tube, a smaller proportion of serous cancers as well as endometroid, clear cell,
      mucinous carcinomas are still thought to arise from ovarian surface epithelium.1&quot; which means
      the exact impact on cancer prophylaxis can only be estimated due to a lack of studies. Other
      histopathologic entities might not be influenced by tube removal.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Longitudinal changes of FSH pre- and post-operatively</measure>
    <time_frame>6 weeks</time_frame>
    <description>Follicle-stimulating hormone (U/l)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Longitudinal changes of AMH</measure>
    <time_frame>6 weeks</time_frame>
    <description>AMH (anti-mullerian hormone, U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longitudinal changes of LH</measure>
    <time_frame>6 weeks</time_frame>
    <description>LH (luteinizing hormone, U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longitudinal changes of E2</measure>
    <time_frame>6 weeks</time_frame>
    <description>E2 (estradiol, U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longitudinal changes of FSH</measure>
    <time_frame>1 year</time_frame>
    <description>Follicle-stimulating hormone (U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longitudinal changes of AMH</measure>
    <time_frame>1 year</time_frame>
    <description>AMH (anti-mullerian hormone, U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longitudinal changes of LH</measure>
    <time_frame>1 year</time_frame>
    <description>LH (luteinizing hormone, U/l)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longitudinal changes of E2</measure>
    <time_frame>1 year</time_frame>
    <description>E2 (estradiol, U/l)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Pelvic Surgery</condition>
  <condition>Routine Fallopian Tube Removal</condition>
  <arm_group>
    <arm_group_label>Surgery with fallopian tube removal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receiving routine fallopian tube removal during pelvic surgery after randomization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery without fallopian tube removal</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Fallopian tubes are not removed during pelvic surgery after randomization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Routine fallopian tube removal</intervention_name>
    <description>Fallopian tubes are removed by dissection of the Mesosalpinx.</description>
    <arm_group_label>Surgery with fallopian tube removal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  benign indication for hysterectomy

          -  informed consent

        Exclusion Criteria:

          -  Menopause

          -  Pregnancy

          -  Previous pelvic surgery (hysterectomy, salpingectomy, tubal ligation,...)

          -  malignancy

          -  hormone replacement therapy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael D Mueller, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University Women's Hospital Bern, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Mohr, Dr. med.</last_name>
    <phone>+4131632</phone>
    <phone_ext>1010</phone_ext>
    <email>stefan.mohr@insel.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael D Mueller, Prof.</last_name>
    <phone>+4131632</phone>
    <phone_ext>1010</phone_ext>
    <email>michel.mueller@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonsspital Baden</name>
      <address>
        <city>Baden</city>
        <zip>5404</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niklaus Hauser, PD Dr. med.</last_name>
      <phone>+4156486</phone>
      <phone_ext>2111</phone_ext>
      <email>niklaus.hauser@ksb.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Women's Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Mohr, Dr. med.</last_name>
      <phone>+4131632</phone>
      <phone_ext>1010</phone_ext>
      <email>stefan.mohr@insel.ch</email>
    </contact>
    <contact_backup>
      <last_name>Michael D Mueller, Prof.</last_name>
      <phone>+4131632</phone>
      <phone_ext>1010</phone_ext>
      <email>michel.mueller@insel.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Dietl J, Wischhusen J, HÃ¤usler SF. The post-reproductive Fallopian tube: better removed? Hum Reprod. 2011 Nov;26(11):2918-24. doi: 10.1093/humrep/der274. Epub 2011 Aug 16. Review.</citation>
    <PMID>21849300</PMID>
  </results_reference>
  <results_reference>
    <citation>Pokoradi AJ, Iversen L, Hannaford PC. Factors associated with age of onset and type of menopause in a cohort of UK women. Am J Obstet Gynecol. 2011 Jul;205(1):34.e1-13. doi: 10.1016/j.ajog.2011.02.059. Epub 2011 Feb 27.</citation>
    <PMID>21514918</PMID>
  </results_reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2016</study_first_submitted>
  <study_first_submitted_qc>January 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2016</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Inselspital, Berne</investigator_affiliation>
    <investigator_full_name>Stefan Mohr</investigator_full_name>
    <investigator_title>Dr. med.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

